BioCentury
ARTICLE | Clinical News

Isomerase Therapeutics, NeuroVive preclinical data

April 28, 2014 7:00 AM UTC

In a mouse model of HBV infection, once-daily 100 mg/kg NVP018 led to a 1.2-1.5 log reduction in HBV DNA levels over 14 days. Data were presented at the European Association for the Study of the Liver...